Mark Cohen

Representing clients ranging from startup ventures to Fortune 500 companies, Mark Cohen is a founder, senior partner, and Chair of the Life Sciences Practice Group of Pearl Cohen Zedek Latzer Baratz, LLP Focusing his practice on intellectual property and commercial transactions in the life sciences field, Mr. Cohen generally handles cases involving matters such as patent prosecution, opinions, due diligence, licensing, service agreements, intellectual property transactions and management, and agreement drafting and negotiations.After earning a Bachelor of Arts in biochemistry from Rutgers College, The State University of New Jersey in 1989, Mr. Cohen went on to attend New York University. From there, he graduated with a Master of Science in biology in 1990. Mr. Cohen received a Juris Doctor from The University of Baltimore School of Law in 1993.Helping clients to manage and monetize their intellectual property assets, Mr. Cohen assists entrepreneurs, startup companies, private businesses and global companies with due diligence matters, patentability opinions, licensing matters, opposition proceedings and infringement validity. His experience includes aiding clients in the pharmaceutical; energy, semiconductors and electronics; life sciences, medical technology, automotive, and defense and aerospace areas. Mr. Cohen is admitted to the New York State Bar Association, and the U.S. Patent and Trademark Office.Involvement in the legal community is a priority for Mr. Cohen. Regularly sharing his knowledge and experience with others, he also lectures before various professional organizations and has published articles in the Nature Biotechnology journal and a number of patent trade journals.Beyond his work in the legal community, Mr. Cohen was a board member for MaSTherCell which was sold to Catalant, Inc., and he previously served as chairman of the board and chairman of the governance and nominating committee for Akari Therapeutics; and Tarus Therapeutics, Inc.